Recently published studies have demonstrated new developments in ulcerative colitis and Crohn’s disease.
In case you missed it, the editors of Healio Gastroenterology and Liver Disease have compiled a recap of some of our most recent popular articles involving inflammatory bowel disease, including an FDA Boxed Warning.
FDA approves boxed warning for Xeljanz in UC
The FDA recently issued a safety alert and approved new Boxed Warning for the 10-mg, twice-daily dosage of Xeljanz in patients with ulcerative colitis; the warning comes after increased blood clot and death risks were seen in a

Source link